Drug Resistance Updates is a bimonthly publication that contains thought-provoking reviews on important developments in drug resistance in infectious disease and cancer as well as novel drugs and strategies to overcome drug resistance.
It covers both basic research and clinical aspects of drug resistance, and involves disciplines as diverse as molecular biology, biochemistry, cell biology, pharmacology, microbiology, preclinical therapeutics, oncology and clinical medicine.
Articles are written by leaders in the field, in response to an invitation from the Editors, and are peer-reviewed prior to publication. Articles are clear, readable, and up-to-date, suitable for a multidisciplinary readership and include schematic diagrams and other illustrations conveying the major points of the article. The goal is to highlight recent areas of growth and put them in perspective.
*Expert reviews in clinical and basic drug resistance research in oncology and infectious disease
*Describes emerging technologies and therapies, particularly those that overcome drug resistance
*Emphasises common themes in microbial and cancer research
《Drug Resistance Updates》是一本由Churchill Livingstone出版商出版的专业医学期刊，该刊创刊于1998年，刊期Bimonthly，该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 1区，小类学科：药学 1区；在JCR（Journal Citation Reports）分区等级为Q1。该刊发文范围涵盖药学等领域，旨在及时、准确、全面地报道国内外药学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为22.841，平均审稿速度约稿?周期不定。
| 大类学科 | 分区 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
| 医学 | 1区 | PHARMACOLOGY & PHARMACY 药学 | 1区 | 是 | 是 |
| JCR分区等级 | JCR所属学科 | 分区 | 影响因子 |
| Q1 | PHARMACOLOGY & PHARMACY | Q1 | 22.841 |
| 影响因子 | h-index | Gold OA文章占比 | 研究类文章占比 | OA开放访问 | 平均审稿速度 |
| 22.841 | 100 | 24.62% | 0.00% | 未开放 | 约稿?周期不定 |
SCI EI SSCI SCOPUS